GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5057-5064

  Zhou, Angela X ^a   Kozhaya, Lina ^a   Fujii, Hodaka ^b   Unutmaz, Derya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; GLYCOPROTEIN A REPETITIONS PREDOMINANT; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMUS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 84877798291     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300065     Document Type: Article

References (55)

1. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
2. + regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13439-13444.
3. Wang, R., Q. Wan, L. Kozhaya, H. Fujii, and D. Unutmaz. 2008. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 3: e2705.
4. + regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13445-13450.
5. Stockis, J., D. Colau, P. G. Coulie, and S. Lucas. 2009. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur. J. Immunol. 39: 3315-3322.
6. D'Alise, A. M., A. Ergun, J. A. Hill, D. Mathis, and C. Benoist. 2011. A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD mice. Proc. Natl. Acad. Sci. USA 108: 8737-8742.
7. Gorelik, L., and R. A. Flavell. 2002. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2: 46-53. (Pubitemid 37328775)
8. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
9. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
10. Marie, J. C., D. Liggitt, and A. Y. Rudensky. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25: 441-454. (Pubitemid 44354215)
11. Li, M. O., S. Sanjabi, and R. A. Flavell. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T celldependent and -independent mechanisms. Immunity 25: 455-471. (Pubitemid 44354214)
12. + regulatory T cells. J. Exp. Med. 201: 1061-1067. (Pubitemid 40524674)
13. +) regulatory T cells. J. Exp. Med. 201: 737-746. (Pubitemid 40395119)
14. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
15. Lucas, P. J., S. J. Kim, S. J. Melby, and R. E. Gress. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J. Exp. Med. 191: 1187-1196. (Pubitemid 30207681)
16. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886. (Pubitemid 38032120)
17. +CD25-T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153. (Pubitemid 38542009)
18. + CD25 -precursors. Am. J. Transplant. 4: 1614-1627. (Pubitemid 39312295)
19. +CD25-cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172: 5213-5221. (Pubitemid 38542018)
20. + T cells in vivo. J. Immunol. 186: 6329-6337.
21. Taylor, A. W. 2009. Review of the activation of TGF-beta in immunity. J. Leukoc. Biol. 85: 29-33.
22. Munger, J. S., X. Huang, H. Kawakatsu, M. J. Griffiths, S. L. Dalton, J. Wu, J. F. Pittet, N. Kaminski, C. Garat, M. A. Matthay, et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328. (Pubitemid 29077586)
23. Mu, D., S. Cambier, L. Fjellbirkeland, J. L. Baron, J. S. Munger, H. Kawakatsu, D. Sheppard, V. C. Broaddus, and S. L. Nishimura. 2002. The integrin alpha(v) beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157: 493-507. (Pubitemid 34839812)
24. Wang, R., J. Zhu, X. Dong, M. Shi, C. Lu, and T. A. Springer. 2012. GARP regulates the bioavailability and activation of TGFb. Mol. Biol. Cell 23: 1129-1139.
25. Travis, M. A., B. Reizis, A. C. Melton, E. Masteller, Q. Tang, J. M. Proctor, Y. Wang, X. Bernstein, X. Huang, L. F. Reichardt, et al. 2007. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449: 361-365. (Pubitemid 47443473)
26. Lacy-Hulbert, A., A. M. Smith, H. Tissire, M. Barry, D. Crowley, R. T. Bronson, J. T. Roes, J. S. Savill, and R. O. Hynes. 2007. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl. Acad. Sci. USA 104: 15823-15828. (Pubitemid 350035383)
27. Yang, Z., Z. Mu, B. Dabovic, V. Jurukovski, D. Yu, J. Sung, X. Xiong, and J. S. Munger. 2007. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176: 787-793. (Pubitemid 46425539)
28. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140.
29. Suzuki, M., K. Abe, K. Yoshinaga, M. Obinata, M. Furusawa, and K. Abe. 1996. Specific arrest of spermatogenesis caused by apoptotic cell death in transgenic mice. Genes Cells 1: 1077-1086. (Pubitemid 126670811)
30. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2: E198.
31. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
32. + human memory T cells. J. Exp. Med. 208: 1875-1887.
33. Oswald-Richter, K., S. M. Grill, M. Leelawong, M. Tseng, S. A. Kalams, T. Hulgan, D. W. Haas, and D. Unutmaz. 2007. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog. 3: e58.
34. Probst-Kepper, M., R. Geffers, A. Kroger, N. Viegas, C. Erck, H. J. Hecht, H. Lunsdorf, R. Roubin, D. Moharregh-Khiabani, K.Wagner, et al. 2009. GARP: a key receptor controlling FOXP3 in human regulatory T cells. J. Cell. Mol. Med. 13(9B): 3343-3357.
35. Rochman, Y., R. Spolski, and W. J. Leonard. 2009. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9: 480-490.
36. + T regulatory cells. J. Immunol. 184: 3433-3441.
37. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16: 1241-1249. (Pubitemid 39220423)
38. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037-1050. (Pubitemid 16000407)
39. Ouyang, W., O. Beckett, Q. Ma, and M. O. Li. 2010. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32: 642-653.
40. +) suppressor T cells in vivo. Nat. Immunol. 3: 33-41. (Pubitemid 34065615)
41. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764. (Pubitemid 47236314)
42. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785. (Pubitemid 47236316)
43. Gravano, D. M., and D. A. Vignali. 2012. The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cell. Mol. Life Sci. 69: 1997-2008.
44. Ikushima, H., and K. Miyazono. 2010. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 10: 415-424.
45. Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949. (Pubitemid 39273735)
46. Turk, M. J., J. A. Guevara-Patino, G. A. Rizzuto, M. E. Engelhorn, S. Sakaguchi, and A. N. Houghton. 2004. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200: 771-782. (Pubitemid 39299463)
47. + T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174: 2591-2601. (Pubitemid 40279672)
48. +) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61: 4766-4772. (Pubitemid 32691889)
49. Chen, M. L., M. J. Pittet, L. Gorelik, R. A. Flavell, R. Weissleder, H. von Boehmer, and K. Khazaie. 2005. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA 102: 419-424. (Pubitemid 40116782)
50. Thomas, D. A., and J. Massagué. 2005. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8: 369-380. (Pubitemid 41579832)
51. +)CD25(-) T cells through secreting TGF-beta. Cancer Lett. 253: 144-153. (Pubitemid 46874736)
52. + T regulatory cells: role of tumor-derived TGF-beta. J. Immunol. 178: 2883-2892. (Pubitemid 46333166)
53. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
54. + FOXP3neg T-cell subsets in cancer patients. Eur. J. Immunol. 42: 1876-1885.
55. Zou, W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5: 263-274. (Pubitemid 40488632)